Micro 2: Protein Synthesis Inhibitors

Similar documents
Protein Synthesis Inhibitors

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

Zyvox. Zyvox (linezolid) Description

Principles of Antimicrobial therapy

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

Appropriate Antimicrobial Therapy for Treatment of

Other Beta - lactam Antibiotics

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Pharmacology Week 6 ANTIMICROBIAL AGENTS

Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

MICU Antibiotics and Associated Drug Interactions

Microbiology ( Bacteriology) sheet # 7

Amoxicillin Introduction: Mechanism of action: Pharmacology: Indications: Dosage: 12 Weeks ( 3 Months):

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets

APPROVED PACKAGE INSERT. Each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin base.

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

Antimicrobials & Resistance

Antibiotics & Resistance

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Antibiotics 1. Lecture 8

Approach to pediatric Antibiotics

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

Antimicrobial Therapy

1. A patient with an allergy to sulfa (sulfonamides) should not take A) Augmentin. B) tetracycline. C) minocycline D) Bactrim DS.

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

1 TRADE NAME OF THE MEDICINAL PRODUCT. Gentamicin Paediatric 20mg/2ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

** the doctor start the lecture with revising some information from the last one:

Chapter 9: Antiinfective Medications Edmunds: Introduction to Clinical Pharmacology, 8th Edition

Health Products Regulatory Authority

Curricular Components for Infectious Diseases EPA

number Done by Corrected by Doctor Dr.Malik

Considerations in antimicrobial prescribing Perspective: drug resistance

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

بسم هللا الرحمن الرحيم

Chapter 46. Learning Objectives (cont d)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Antimicrobial Therapy

POTENTIAL HARMS OF ANTIBIOTIC USE. A Ben Appenheimer MD Infectious Diseases University of Iowa Hospitals and Clinics

Published with the permission of LAVC Close window to return to IVIS pág 65 The Latin American Veterinary Conference TLAVC 2006

Antibiotic Updates: Part I

Abx II: Inhibitors of Protein Synthesis. Aminoglycosides/Aminocyclitols Gentamicin/Streptomycin, Spectinomycin. VPM 201: Lewis-11: Abx II

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Cell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification

Topical Antibiotic Update. Brad Sutton, O.D., F.A.A.O. Indiana University School of Optometry Indianapolis Eye Care Center No financial disclosures

Chemotherapeutic Agents

Responsible use of antibiotics

Is erythromycin bactericidal

Can fluconazole treat c diff

Antimicrobial agents. are chemicals active against microorganisms

UPDATES ON ANTIBIOTIC THERAPY. Jennifer L. Davis, DVM, PhD, DACVIM (LA), DACVCP VA-MD College of Veterinary Medicine VA Tech, Blacksburg, VA

B. PACKAGE LEAFLET 1

Introduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail.

Advanced Practice Education Associates. Antibiotics

Antimicrobials. Antimicrobials

Pharmacokinetic & Pharmadynamic of Once Daily Aminoglycosides (ODA) and their Monitoring. Janis Chan Pharmacist, UCH 2008

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Antibiotics (2): - Before you start: this lecture has a lot of names and things get entangled together, but I

3/23/2017. Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc. Kathryn G. Smith: Nothing to disclose

number Done by Corrected by Doctor

Part II SUMMARY OF PRODUCT CHARACTERISTICS. Each tablet contains 25 mg Clindamycin (as Clindamycin Hydrochloride)

ANNEX III AMENDMENTS TO THE SUMMARY OF PRODUCT CHARACTERISTICS AND PACKAGE LEAFLET

Can i take diflucan with antibiotics

Disclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

SUMMARY OF PRODUCT CHARACTERISTICS

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only

DNA Gyrase Inhibitors, Sulfa drugs and VRE

ECHO: Management of URIs. Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018

Staph Cases. Case #1

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

folate-derived cofactors purines pyrimidines Sulfonamides sulfa drugs Trimethoprim infecting bacterium to perform DNA synthesis cotrimoxazole

11/2/2015. Update on the Treatment of Clostridium difficile Infections. Disclosure. Objectives

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

SUMMARY OF PRODUCT CHARACTERISTICS

Introduction to Antimicrobial Therapy

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

Chapter 51. Clinical Use of Antimicrobial Agents

Importance of Frequency Homeopathic application

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION:

Chapter 14. Antimicrobial Agents. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.

Patients. Excludes paediatrics, neonates.

SUMMARY OF PRODUCT CHARACTERISTICS

Role of IV Therapy in Bone and Joint Infection

Updated recommended treatment regimens for gonococcal infections and associated conditions United States, April 2007

Mike Apley Kansas State University

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

WHY IS THIS IMPORTANT?

Introduction to Pharmacokinetics and Pharmacodynamics

ECOLOGICAL IMPACT OF NARROW SPECTRUM ANTIMICROBIAL AGENTS COMPARED TO BROAD SPECTRUM AGENTS ON THE HUMAN INTESTINAL MICROFLORA CARL ERIK NORD

Transcription:

Gentamicin gen tah MY sin Streptomycin strep toe MYE sin Clindamycin klin da MYE sin Quinupristin + Dalfopristin KWIN-ue-PRIStin/DAL-foe-PRIS-tin Garamycin NA Clindamax, Cleocin Synercid 1) Class: Aminoglycoside 2) Indication: mostly for serious Gram infections. a) Bactericidal b) Boxed warnings: ototoxicity, kidney failure and neuromuscular blockade. Fetotoxic. c) No PO. Available IM or IV (Usually TID 7-10 d), topical (cream, ointment, ophthalmic solution) e) Loop diuretics increase ototoxicity risk 1) Class: Aminoglycoside 2) Indication: IM for serious infections, including, potentially, TB. a) BW: ototoxicity, kidney failure, NMJ blockade. Fetotoxic. b) Give no more than 120 grams over entire course of therapy. c) Bactericidal 1) Class: Lincosamide = Restricted Range 2) Indication: SEVERE RTI, skin and soft tissue infections not treatable with other antibiotics. a) PO, IM, IV, Topicals b) Adults usually QID, Kids TID/QID i) PO: Take with a full glass of water to avoid irritation ii) IV: contains benzyl alcohol which may cause Gasping Syndrome in neonates c) BW: CDAD d) Curare- like effect e) Will exacerbate colitis and other GIT conditions f) May contain tartrazine g) Bacteriostatic 1) Resistance is common 1) Class: Streptogramin 2) Indication: Specific, serious, life- threatening infections a) P450 Inhibitors 4) Bacteriostatic alone; Bactericidal together Page 1 of 5

Azithromycin ay-zith-roe-myesin Erythromycin eh-rith-row-mysin Zithromax E- mycin, EryPed, Erythrocin, Eryzole, Pediazole 1) Class: Macrolide 2) Indication: mild to moderate RTI & UTI (including acute otitis media, pharyngitis, tonsillitis, GIT infections, etc.) a) PO/IV infusion SID 2-5 days (not acid stable, so pills are do not crush). NO IM. i) Give loading dose ii) Extended- release is NOT bioequivalent to or interchangeable with conventional formulas b) Ophthalmic (AzoSite) must be refrigerated c) Extremely long t ½ (~70 hours) i) Allergic reactions can occur weeks after treatment ii) Enterohepatically cycled (mainly excreted unchanged in bile) d) Long term use may cause hearing loss e) Bacteriostatic 4) Resistance is common 1) Class: Macrolide 2) Indication: Usually used in people allergic to penicillin for mild/moderate RTI, UTI and acne. Prokinetic alternative to metoclopramide for gastroparesis. a) PO, IV infusion (not acid stable, so pills are do not crush ) i) Normally give PO 2 hours before meal. Formulations available that can be given without regard to meals (chewable tablets and film- coated tablets). ii) Must adjust dose in kidney patients b) POTENT P450 INHIBITOR (Lots of drug interactions related to CYP3A4 inhibition) c) Half life 1.5 2 hours d) Bacteriostatic 4) Resistance is common Page 2 of 5

Chloramphenicol KLOR-am-FEN-ihkahl Chloromycetin 1. Broad spectrum antibiotic 2. Indications: life- threatening infections for which other drugs cannot be used. 3. Notes: a) Available PO, IV and in ophthalmic and otic solutions. i) Avoid repeated courses ii) Causes a bitter taste 15-20 seconds after injection that lasts for about 3-5 minutes. iii) Narrow therapeutic margin!! (1) Monitor plasma levels (2) Monitor body temperature every 4 hours until temp is normal for 48 hours, then discontinue chloramphenicol (3) Lots of individual/age differences (a) Succinate is a Prodrug, metabolized by liver, lung, kidney leading to variable IV bioavailability! (b) Half life in normal adult = 1.5 4.5 hours (c) Half life in neonates/infants >= 24 hours (d) Impaired liver function increases half life b) Bacteriostatic c) Resistance is common d) Less likely to cause CDAD than other antibiotics e) Suppresses bone marrow (BW: serious and potentially fatal blood dyscrasias aplastic anemia, hypoplastic anemia, thrombocytopenia, granulocytopenia). i) May be irreversible. ii) Monitor hematologic function before and then every other day during therapy. (1) CBC, platelets, serum iron, reticulocytes f) Long- term therapy leads to optic and peripheral neuropathies g) Gray (baby) Syndrome i) Neonates develop hypotension, cyanosis because they can t metabolize chloramphenicol. Potentially fatal. h) P450 INHIBITOR i) LOTs of drug interactions i) Increases the activity of sulfonylureas (increased risk of hypoglycemia) Page 3 of 5

Linezolid lin-aze-oh-lid Doxycycline DOX i SYE kleen Tetracycline tet rah SYE kleen Zyvox Vibramycin, Adoxa, Oracea Sumycin 1) Class: Oxazolidinone 2) Indication: serious Gram + infections a) PO/IV usually TID b) Bacteriostatic c) MAO- I activity i) Avoid adrenergic and serotonergic drugs (1) E.g., OTC decongestants, SSRIs, SNRIs, TCAs, MAOIs ii) Avoid use in Hypertensive and/or hyperthyroid patients iii) Avoid tyramine rich foods (serotonin syndrome risk) d) Monitor CBCs weekly during therapy due to myelosuppression i) Thrombocytopenia e) Optic and peripheral neuropathies possible i) May cause vision loss monitor visual function in patients on linezolid for more than 28 days or if patient reports visual changes f) Lactic acidosis possible g) Decreases seizure threshold h) Contains aspartame (which is metabolized to phenylalanine) i) Protect tablets from light 4) Resistance is rare and mostly in Enterococci 1) Class: Broad spectrum Tetracycline 2) Indications: G+, G-, Protozoa, Rickettsia, Spirochetes a) NOT FOR STAPH infections b) PO, IV infusion usually SID or BID and may be given chronically (e.g., for weeks or months) c) Bacteriostatic e) Antibiotic of choice if patient is in renal failure f) Strong photosensitizer g) Don t take with divalent cations (NO DAIRY!!! No vitamin supplements, no antacids.) h) Permanently stains developing teeth brown i) Drug interactions: i) Divalent cations inactivate tetracyclines ii) Methoxyflurane may cause fatal renal toxicity with tetracyclines iii) Prothrombin time is increased (plasma prothrombin is suppressed) will increase Warfarin effects. Oral birth control pills may have reduced efficacy 1) SAME AS DOXYCYCLINE 2) SAME AS DOXYCYCLINE SAME AS DOXYCYLINE, except available PO, IV, IM and in Topicals. Tetracycline has a much shorter t ½ so is administered more often. Page 4 of 5

ADDITIONAL NOTES: Micro 2: Protein Synthesis Inhibitors 1. All of these antibiotics are protein synthesis inhibitors. 2. All antibiotics have the ability to cause Superinfections which are usually Clostridium difficile (anaerobic bacteria, part of the normal GIT flora) and/or Candida albicans (a fungus, a yeast, normally found on our bodies and on mucous membranes of the mouth, nose, and parts of the genitourinary tract). Oral antibiotics are more likely to disrupt the GIT microflora leading to a C. diff. infection, but any antibiotic can cause a Superinfection. a. Candida may be treated with an antifungal. For mild infections, Clotrimazole or a similar antifungal may be used. For more serious infections, Fluconazole or a similar antifungal may be used. For life threatening infections, Amphotericin B may be used. See Micro 5 for the antifungals. b. C. difficile may be treated with Metronidazole (Flagyl, see Micro 4). 3. You need to focus on the Generic and names, the class, know the mechanism (protein synthesis inhibitors) and the NOTES. If it s bold and in the NOTES, know it. 4. All the indications listed in this table and in lecture are generalized from the labels. All antibiotics have specific bacteria (usually by species) for which they have documented activity. These lists can be very, very long and I ve chosen to simplify the material. a. Resistance is COMMON. b. All antibiotics are indicated for SUSCEPTIBLE strains of the bacteria listed on their labels. Just because an antibiotic is indicated for Pseudomonas aeruginosa, for instance, doesn t mean it will work or should be used. Cultures must be grown to determine susceptibility. In practice, this is often not done, leading to resistant strains. 5. Except for the aminoglycosides, the protein synthesis inhibitors are considered to be bacteriostatic. In practice, many, like the Macrolides, are bactericidal. It depends upon the individual circumstances. 6. Oral antibiotics, of any kind, may interfere with the enterohepatic cycling of drugs that are conjugated in the liver and reabsorbed from the intestines after GIT bacteria cleave off the conjugate. This includes oral birth control pills (expect reduced efficacy of the birth control pills), so patients taking oral contraceptives should be cautioned to use a secondary method of birth control. Page 5 of 5